Navigation Links
Biocides that attack only insects
Date:6/28/2011

This release is available in Spanish.

Biocides turn out to be less toxic for the environment if they are subjected to microencapsulation, due to the fact that this process forms shell(s) for the substance. This is the conclusion of chemist Ms Mariluz Alonso in a thesis defended at the University of the Basque Country (UPV/EHU). In this research, she chose a number of biocides and other complementary substances, seeking a micro-encapsulation which, besides being compatible with the environment, is more soluble in water, more manageable for the operator, with better conditions of conservation, and effective against airborne insects. Her thesis is entitled Micro-encapsulation of biocides, and has given rise to publications in journals such as the International Journal of Environmental Analytical Chemistry (the article is entitled Advantages of biocides-β-cyclodextrin inclusion complexes against active components).

The aim of the researcher was to obtain a product that overcame the limits of common biocides. These limits correspond to a toxicological profile that restricts their use, poor solubility in water, high viscosity (in some cases) that complicates their handling, and high sensitivity (in most cases) to light and temperature. The product not only complies with these parameters, but has also shown that it is effective against the domestic fly, in tests undertaken in the laboratory.

Cyclodextrine as encapsulating agent

In order to form this product Ms Alonso chose the carbamate insecticides (concretely, bendiocarb) - nicotinoids and pyrethroids. Carbamates are less damaging for the environment than others, more biodegradable and less toxic for humans. Their great disadvantage is that insects can become resistant to them. Nicotinoid and pyrethroid insecticides, on the other hand, do not have any disadvantage with respect to resistance. Nicotinoids are applied particularly in horticulture, because they are safer for bees. Pyrethroids are the most commonly used, being characterised by their low toxicity towards mammals, although are toxic to bees and aquatic organisms.

Moreover, the researcher intensified the activity of the pyrethroids, including piperonyl butoxide (Pb) in the microencapsulation. This is a substance that increases the efficacy of this insecticide between 10 and 150 times. Within the study she also managed to encapsulate tebuconazole fungicide.

As regards microencapsulation itself, the researcher opted for cyclodextrine-type (CD) carbohydrates as an encapsulating agent. Carbohydrates have high aqueous solubility, little tendency to absorb humidity, a high average lifespan at ambient temperature and are low cost. Cyclodextrines, in concrete, are cyclical dextrines obtained from the partial hydrolysis of maize starch. Also, a yield greater than 99 % was obtained in the formation of microcapsules, on applying a method for dissolution with organic solvents optimised in the laboratory where the research was undertaken.

Less detectable for insects

As was concluded in the thesis, thanks to the micrometric size of the encapsulations obtained, the product has the advantage of being able to treat a greater surface area and being less detectable for insects. Moreover, thanks to the CD protecting the biocide, its toxicological profile is neutralised and its degradation through storage reduced. Besides, on enhancing the solubility of the compound (and thus it being possible to prepare the commercial product based on water) the use of petroleum-derived solvents is avoided, enabling the manufacture of products that are more environmentally-friendly. Finally, the difficulty arising in handling liquid biocides at ambient temperature is overcome with the formation itself of these microencapsulations.

Ms Alonso has been able to demonstrate in the laboratory the insecticide efficacy of the product against the household fly. This result acts as a basis for obtaining effective formulae which can be applied to various types of insects in general and to domestic flies in particular, both indoors and outdoors.


'/>"/>

Contact: Amaia Portugal
a.portugal@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related biology news :

1. Dark chocolate: Half a bar per week to keep at bay the risk of heart attack
2. Entertainment Software Association Foundation awards grant to FAS for immune attack
3. When under attack, plants can signal microbial friends for help
4. Researchers at UH explore use of fat cells as heart attack therapy
5. Gene against bacterial attack unravelled
6. Syracuse University researchers discover new way to attack some forms of leukemia
7. Damage inflicted during cardiac attacks more widespread, MSU researchers find
8. Preventing a broken heart: Research aims to reduce scarring from heart attacks
9. Reducing the damage of a heart attack
10. Heart attacks: The tipping point
11. International study identifies gene variants associated with early heart attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... HILLS, Mich. , Dec. 15, 2016  There ... unlocking car doors or starting the engine. Continental will ... in Las Vegas . Through the ... (Passive Start and Entry) and biometric elements, the international ... field of vehicle personalization and authentication. "The ...
(Date:12/8/2016)... 8, 2016 Market Research Future published a half cooked ... Mobile Biometric Security and Service Market is expected to grow over ... Market Highlights: ... Mobile Biometric Security and Service ... increasing need of authentication and security from unwanted cyber threats. The ...
(Date:12/7/2016)... AVIV, Israel , December 7, 2016 ... with the expansion of its patent portfolio, which grew to over 40 ... , , ... by its recently filed patent entitled " System, Device, and ... covers technology that enables device makers to forego costly hardware components needed ...
Breaking Biology News(10 mins):
(Date:1/23/2017)... Jan. 23, 2017  Alkahest Inc. ("Alkahest"), a ... neurodegenerative diseases and other age-related conditions, announced today ... as Chief Medical Officer. In this role, Dr. ... activities at Alkahest and serve on the Executive ... served as Executive Director at Dynavax, where he ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... endeavors to bring to market a pioneering medical device for the treatment of ... an engagement contract with Emergo, a global regulatory consultancy that helps companies like ...
(Date:1/20/2017)... ... January 20, 2017 , ... The two newest companies ... options for patients. Vironika, a spin out from The Wistar Institute, and Sanguis, launched ... space at 3624 Market Street. , Vironika is developing a treatment for a ...
(Date:1/19/2017)... Research and Markets has announced the addition of the ... Global Opportunity Analysis and Industry Forecast, 2014-2022" report to their ... Cancer ... reach $15,737 million by 2022 from $6,521 in 2015, growing at ... Omic technologies segment accounted for more than half of the revenue ...
Breaking Biology Technology: